6-(4-acetylpiperazin-1-yl)-N-benzyl-N-methyl-3,4-dihydroquinoline-1(2H)-sulfonamide

ID: ALA4745031

Chembl Id: CHEMBL4745031

PubChem CID: 162648823

Max Phase: Preclinical

Molecular Formula: C23H30N4O3S

Molecular Weight: 442.59

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N1CCN(c2ccc3c(c2)CCCN3S(=O)(=O)N(C)Cc2ccccc2)CC1

Standard InChI:  InChI=1S/C23H30N4O3S/c1-19(28)25-13-15-26(16-14-25)22-10-11-23-21(17-22)9-6-12-27(23)31(29,30)24(2)18-20-7-4-3-5-8-20/h3-5,7-8,10-11,17H,6,9,12-16,18H2,1-2H3

Standard InChI Key:  HGIVSBUXSHCSJC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4745031

    ---

Associated Targets(Human)

RORC Tchem Nuclear receptor ROR-gamma (8495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.59Molecular Weight (Monoisotopic): 442.2039AlogP: 2.48#Rotatable Bonds: 5
Polar Surface Area: 64.17Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.58CX LogP: 1.95CX LogD: 1.95
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.71Np Likeness Score: -1.64

References

1. Sun,N.; Ma,X.; Zhou,K.; Zhu,C.; Cao,Z.; Wang,Y.; Xu,J.; Fu,W..  (2020)  Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases.,  187  [PMID:31881455] [10.1016/j.ejmech.2019.111984]

Source